Skip to main content

Reviva Pharmaceuticals Holdings, Inc ARS, filed Nov 9, 2026

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

Reviva Pharmaceuticals Holdings, Inc. effected a one-for-twenty reverse stock split effective March 9, 2026, then closed a public offering on March 20, 2026 that generated approximately $8.9 million in net proceeds. AI summary

ARS 2026-11-09 For: 2025-12-31
View Original
Added on November 10, 2026